Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review
- PMID: 36747991
- PMCID: PMC9898069
- DOI: 10.1016/j.pmedr.2023.102111
Barriers to and facilitators of hormonal and long-acting reversible contraception access and use in the US among reproductive-aged women who use opioids: A scoping review
Abstract
Existing research has found that women who use opioids (WWUO) experience challenges to hormonal and long-acting reversible contraception (HC-LARC) access and use. Facilitators of such use are unclear. We conducted a scoping review to comprehensively map the literature on barriers to and facilitators of HC-LARC access and use in the United States among reproductive-aged WWUO. In accordance with the JBI Manual of Evidence Synthesis, we conducted literature searches for empirical articles published from 1990 to 2021. Independent reviewers screened references, first by titles and abstracts, then by full-text, and charted data of eligible articles. We coded and organized HC-LARC barriers and facilitators according to a four-level social-ecological model (SEM) and categorized findings within each SEM level into domains. We screened 4,617 records, of which 28 articles focusing on HC-LARC (n = 18), LARC only (n = 6), or testing an intervention to increase HC-LARC uptake (n = 4) met inclusion criteria. We identified 13 domains of barriers and 11 domains of facilitators across four SEM levels (individual, relationship, community, societal). The most frequently cited barriers and facilitators were methods characteristics, partner and provider relations, transportation, healthcare availability and accessibility, cost, insurance, and stigma. Future studies would benefit from recruiting participants and collecting data in community settings, targeting more diverse populations, and identifying neighborhood, social, and policy barriers and facilitators. Reducing barriers and improving equity in HC-LARC access and use among WWUO is a complex, multifaceted issue that will require targeting factors simultaneously at multiple levels of the social-ecological hierarchy to effect change.
Keywords: Contraceptive access; Hormonal contraception; Long-acting reversible contraception; Opioid use; Opioid use disorder; Opioids; Scoping review.
© 2023 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Mapping Long-acting Reversible Contraceptive Interventions to the Social Ecological Model: A Scoping Review.Womens Health Issues. 2023 Sep-Oct;33(5):497-507. doi: 10.1016/j.whi.2023.06.005. Epub 2023 Jul 25. Womens Health Issues. 2023. PMID: 37500420 Free PMC article.
-
Provider Perspectives of Barriers to Contraceptive Access and Use among Women with Substance Use Disorders.Womens Health Issues. 2022 Mar-Apr;32(2):165-172. doi: 10.1016/j.whi.2021.11.010. Epub 2021 Dec 17. Womens Health Issues. 2022. PMID: 34930641
-
Determinants of Long-acting Reversible Contraception (LARC) Initial and Continued Use among Adolescents in the United States.Adolesc Res Rev. 2020 Sep;5(3):243-279. doi: 10.1007/s40894-019-00126-w. Epub 2019 Jul 12. Adolesc Res Rev. 2020. PMID: 34056060 Free PMC article.
-
Views and experiences of long-acting reversible contraception among ethnic minorities in high-income countries: a systematic review of qualitative studies.BMJ Sex Reprod Health. 2024 Jan 9;50(1):53-66. doi: 10.1136/bmjsrh-2023-201864. BMJ Sex Reprod Health. 2024. PMID: 37949640
Cited by
-
Healthcare providers' perceptions on post abortion intrauterine contraception: A qualitative study in central Uganda.PLoS One. 2024 Dec 5;19(12):e0301748. doi: 10.1371/journal.pone.0301748. eCollection 2024. PLoS One. 2024. PMID: 39636829 Free PMC article.
-
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis.Addict Sci Clin Pract. 2025 Jan 6;20(1):1. doi: 10.1186/s13722-024-00530-1. Addict Sci Clin Pract. 2025. PMID: 39762993 Free PMC article.
References
-
- Arksey H., O'Malley L. Taylor and Francis Group Ltd; 2005. Scoping studies: Towards a Methodological Framework, International Journal of Social Research Methodology: Theory and Practice; pp. 19–32.
-
- Armstrong K.A., Kenen R., Samost L. Barriers to family planning services among patients in drug treatment programs. Fam. Plann. Perspect. 1991;23(264–6):70. - PubMed
-
- Asker C., Stokes-Lampard H., Beavan J., Wilson S. What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study. J. Fam. Plann. Reprod. Health Care. 2006;32:89–94. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous